Subject(s)
COVID-19 , Precancerous Conditions , Uterine Cervical Neoplasms , Humans , Female , United States/epidemiology , COVID-19/epidemiology , Racial Groups , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/pathology , Precancerous Conditions/epidemiology , Precancerous Conditions/pathology , Health Status Disparities , Healthcare DisparitiesABSTRACT
CONTEXT.: This review article is a result of the breast pathology lectures given at the Sixth Chinese American Pathologists Association annual diagnostic pathology course in October 2020 (held virtually due to COVID-19). OBJECTIVE.: To update recent developments, in this review article, the authors wrote minireviews in the following 4 areas: lobular neoplasm, adenomyoepithelial lesions, papillary lesions, and fibroepithelial lesions. DATA SOURCES.: The sources include extensive literature review, personal research, and experience. CONCLUSIONS.: With the wide practice of screening mammography, these lesions are not uncommon in image-guided core biopsies and excisional specimens. Many recent developments have emerged in understanding these lesions. We aim to provide readers with concise updates for each of these lesions with a focus on recent updates in definitions, diagnostic criteria, management, and molecular profiles that are most relevant to the daily practice of pathology and patient management.